CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 1 | 913↑126893.2% | 0↓100.0% | 370↑84762.4% | 35↓90.5% |
| Gross Profit | -269 | 812↑402.2% | -110↓113.5% | 240↑318.3% | -75↓131.4% |
| Operating Income | -354 | 374↑205.4% | -673↓280.2% | -223↑66.9% | -467↓109.7% |
| Net Income | -349 | 378↑208.3% | -650↓272.2% | -154↑76.4% | -366↓138.4% |
| EBITDA | -345 | 391↑213.4% | -649↓265.8% | -203↑68.8% | -447↓120.7% |
| EPS Diluted | -5.29 | 4.70↑188.8% | -8.36↓277.9% | -1.94↑76.8% | -4.34↓123.7% |